VGG2161P1403 - Common Stock
CHINA SXT PHARMACEUTICALS IN
NASDAQ:SXTC (12/18/2024, 10:33:58 AM)
0.349
+0.01 (+2.32%)
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300
P: 8652386298290
CEO: Feng Zhou
Employees: 75
Website: http://www.sxtchina.com/
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Get insights into the top gainers and losers of Monday's pre-market session.
Jiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on...
Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.
Here you can normally see the latest stock twits on SXTC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: